KLF5 was found to be upregulated in renal tissues of mice with diabetic nephropathy (DN), and inhibited KLF5 could relieve podocyte injury, which may be helpful for establishing a novel DN therapy.15 This evidence concerns the gene KLF5 and diabetic kidney disease.